Innovation portfolio management software
Your growth plan has a gap. EVOS shows you exactly where it is.
EVOS reads the patents, filings, competitor moves and customer calls your team never has time for, in hours, not months. It measures the gap between the growth you've promised and what your products will deliver, then hands you the scored, sized bets that close it.
Find it. Size it. Track it.
Find
Your strengths × real market pain × technology that's ready. EVOS scores every opportunity on all three and surfaces the ones that hit all three.
Size
Bottom-up numbers from products, customers, units and dates. Not TAM. A real number.
Track
Signals watches every bet, around the clock. A competitor files, a trial slips, a customer signs a letter of intent: your plan updates and you see what's at stake.
You promised 12%. Your products deliver 4%.
Market reports tell you what already happened. EVOS tells you what happens next: which products will carry next year’s revenue, how many projects you need in development to get one to market, and when each has to start to arrive in time.
No more growth decks that fall apart on the analyst call. Here's the gap. Here's what closes it. Here's what you lose if you don't fund it.
Innovation management software that starts with evidence, not a suggestion box
Most innovation software is idea management with better branding. It collects suggestions and ranks what you already thought of. EVOS starts from the evidence and tells you what to build.
| Typical innovation management tools | EVOS |
|---|---|
| Collect ideas | Read the evidence: patents, markets, competitors, customer calls |
| Rank what you already thought of | Show what your products can't deliver, and what will |
| Stop at launch | Watch the market before and after launch, and re-forecast |
| Need a program and a team to feed them | One scan of one product line gives you an answer |
| Organic only | Build, buy and partner, side by side |
Built for the people who own the number
Everything your company knows. One system.
Your experts stay in their silos. EVOS sits on top, pulls every note, call and filing into one place, and ties each one to the goal it serves.
We pointed the method at Roche's public record. It called the revenue mix seven years early.
Half of Roche Pharmaceuticals' revenue was heading off patent. The pipeline evidence already showed what would replace it.
Your IT team will ask. Here are the answers.

Rather have it done for you? Rapid Alpha, the growth advisory firm behind EVOS, runs on it. rapidalpha.com →
Show us one product line. We'll show you its gap.
45 minutes. Your market, loaded before the call. Your gap, in dollars, and the bets that close it.